Virological outcome and patterns of HIV‐1 drug resistance in patients with 36 months' antiretroviral therapy experience in Cameroon

AF Aghokeng, C Kouanfack… - Journal of the …, 2013 - Wiley Online Library
Introduction The current expansion of antiretroviral treatment (ART) in the developing world
without routine virological monitoring still raises concerns on the outcome of the strategy in …

Virological outcome and patterns of HIV‐1 drug resistance in patients with 36 months' antiretroviral therapy experience in Cameroon

AF Aghokeng, C Kouanfack… - African Journal of …, 2013 - journals.lww.com
Introduction: The current expansion of antiretroviral treatment (ART) in the developing world
without routine virological monitoring still raises concerns on the outcome of the strategy in …

[HTML][HTML] Virological outcome and patterns of HIV-1 drug resistance in patients with 36 months' antiretroviral therapy experience in Cameroon

AF Aghokeng, C Kouanfack… - Journal of the …, 2013 - ncbi.nlm.nih.gov
Methods We consecutively recruited between 2008 and 2009 patients attending a national
reference clinic in Yaoundé–Cameroon, for their routine medical visits at month 36±2 …

[PDF][PDF] Virological outcome and patterns of HIV-1 drug resistance in patients with 36 months' antiretroviral therapy experience in Cameroon

AF Aghokeng, C Kouanfack, S Eymard-Duvernay… - 2013 - academia.edu
Introduction: The current expansion of antiretroviral treatment (ART) in the developing world
without routine virological monitoring still raises concerns on the outcome of the strategy in …

Virological outcome and patterns of HIV-1 drug resistance in patients with 36 months' antiretroviral therapy experience in Cameroon

AF Aghokeng, C Kouanfack… - … AIDS Society. Journal, 2013 - hero.epa.gov
INTRODUCTION: The current expansion of antiretroviral treatment (ART) in the developing
world without routine virological monitoring still raises concerns on the outcome of the …

Virological outcome and patterns of HIV-1 drug resistance in patients with 36 months' antiretroviral therapy experience in Cameroon

FA Aghokeng, C Kouanfack, S Eymard-Duvernay… - 2013 - documentation.ird.fr
Introduction: The current expansion of antiretroviral treatment (ART) in the developing world
without routine virological monitoring still raises concerns on the outcome of the strategy in …

Virological outcome and patterns of HIV-1 drug resistance in patients with 36 months' antiretroviral therapy experience in Cameroon.

AF Aghokeng, C Kouanfack… - Journal of the …, 2013 - search.ebscohost.com
Introduction: The current expansion of antiretroviral treatment (ART) in the developing world
without routine virological monitoring still raises concerns on the outcome of the strategy in …

Virological outcome and patterns of HIV-1 drug resistance in patients with 36 months' antiretroviral therapy experience in Cameroon.

AF Aghokeng, C Kouanfack… - Journal of the …, 2013 - europepmc.org
Methods We consecutively recruited between 2008 and 2009 patients attending a national
reference clinic in Yaoundé-Cameroon, for their routine medical visits at month 36±2 …

Virological outcome and patterns of HIV-1 drug resistance in patients with 36 months' antiretroviral therapy experience in Cameroon

AF Aghokeng, C Kouanfack… - Journal of the …, 2013 - pubmed.ncbi.nlm.nih.gov
Introduction The current expansion of antiretroviral treatment (ART) in the developing world
without routine virological monitoring still raises concerns on the outcome of the strategy in …

Virological outcome and patterns of HIV‐1 drug resistance in patients with 36 months' antiretroviral therapy experience in Cameroon

AF Aghokeng, C Kouanfack… - Journal of the …, 2013 - search.proquest.com
Methods We consecutively recruited between 2008 and 2009 patients attending a national
reference clinic in Yaoundé–Cameroon, for their routine medical visits at month 36±2 …